Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Business

PetMed CFO says allegations of marketing to opioid addicts are 'bogus'

SAN FRANCISCO (Reuters) - A short seller's allegations that PetMed Express markets pet medicine to human opioid addicts are "bogus," PetMed Chief Financial Officer Bruce Rosenbloom told Reuters on Wednesday.

PetMed's stock slumped 17 percent on Wednesday following the release of a report by Aurelius Value, which said it has shorted the shares. The report alleges that PetMed deliberately targets opioid addicts in its online marketing for pet pain killers.

(Reporting by Noel Randewich; Editing by Paul Simao)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.